-
admin
Posts
Meihua International Medical Technologies Co., Limited Reports Unaudited 2024 First Half Financial Results
YANGZHOU, China, Sept. 21, 2024 /PRNewswire/ — Meihua International Medical Technologies Co., Ltd. (“MHUA” or the “Company”) (Nasdaq: MHUA), a reputable manufacturer and provider of...
Carolina Dybeck Happe resigns from Ericsson’s Board of Directors
STOCKHOLM, Sept. 21, 2024 /PRNewswire/ — Ericsson (NASDAQ: ERIC) today announces that Carolina Dybeck Happe has decided to resign from its Board of Directors. Dybeck...
PRADA SPRING/SUMMER 2025 WOMENSWEAR SHOW
Beauty looks created by Lynsey Alexander, Global Creative Makeup Artist of Prada Beauty MILAN, Sept. 21, 2024 /PRNewswire/ — The Prada Spring/Summer 2025 Womenswear fashion show was...
Fosi Audio Launches 7th Anniversary Celebration with the Theme “Your Voice Rocks & Sparks”
NEW YORK, Sept. 20, 2024 /PRNewswire/ — Fosi Audio, a beloved brand among audiophiles worldwide, has officially launched its grand 7th-anniversary celebration under the theme “Your...
Open letter from the Chief Executive Officer.
HOLLYWOOD, FL, Sept. 20, 2024 (GLOBE NEWSWIRE) — Healthy Choice Wellness Corp. (“HCWC” or the “Company”) (NYSEAM: HCWC), a holding company focused on providing consumers...
UAE Cosmetic Pigments Market Trends, Competitive Landscape, Forecast and Opportunities, 2024-2029
Dublin, Sept. 20, 2024 (GLOBE NEWSWIRE) — The “UAE Cosmetic Pigments Market, By Region, Competition, Forecast and Opportunities, 2019-2029F” report has been added to ResearchAndMarkets.com’s...
Honey Powder Market Report 2024-2030: Organic, Conventional, Food & Beverages, Beauty, Personal Care Size, Share & Trends Analysis
Dublin, Sept. 20, 2024 (GLOBE NEWSWIRE) — The “Honey Powder Market Size, Share & Trends Analysis Report By Type (Organic, Conventional), By Application (Food &...
Samsung Bioepis and Biogen Receive Positive CHMP Opinion for Aflibercept Biosimilar, OPUVIZ™
OPUVIZ™, a biosimilar referencing Eylea1 (aflibercept), is Samsung Bioepis and Biogen’s second ophthalmology biosimilar to be recommended for marketing authorization by the European Medicines Agency...
Dupixent® (dupilumab) Recommended for EU Approval by the CHMP to Treat Eosinophilic Esophagitis (EoE) in Children as Young as 1 Year Old
Recommendation based on a Phase 3 trial showing a significantly greater proportion of children on Dupixent achieved histological remission compared to placebo, consistent with improvements...
Press Release: Dupixent recommended for EU approval by the CHMP to treat eosinophilic esophagitis in children as young as 1 year old
Dupixent recommended for EU approval by the CHMP to treat eosinophilic esophagitis in children as young as 1 year old Recommendation based on a phase...
